PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
Keywords: Non-small-cell lung cancer; PD-L1 expression; Circulating tumor cells; Monitoring of response; Immunotherapy; Anti-PD1;